(Q50585129)

16 March 2018

title

Clinical trials of TB vaccines: harmonization and cooperation. (English)

1 reference

16 March 2018

1 reference

Hassan Mahomed

1

1 reference

16 March 2018

P Bernard Fourie

series ordinal

2

1 reference

16 March 2018

publication date

1 March 2012

1 reference

16 March 2018

published in

Tuberculosis

1 reference

16 March 2018

volume

92 Suppl 1

1 reference

16 March 2018

page(s)

S21-4

1 reference

16 March 2018

Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2812%2970008-2

7 January 2021

The Development and Impact of Tuberculosis Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2812%2970008-2

7 January 2021

Prospects for a new, safer and more effective TB vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2812%2970008-2

7 January 2021

Tuberculosis vaccines in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2812%2970008-2

7 January 2021

Rational approach to selection and clinical development of TB vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2812%2970008-2

7 January 2021

Variation in protection by BCG: implications of and for heterologous immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2812%2970008-2

7 January 2021

Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2812%2970008-2

7 January 2021

Phenotypic variability in childhood TB: implications for diagnostic endpoints in tuberculosis vaccine trials

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2812%2970008-2

7 January 2021

Safety and efficacy of the RTS, S/AS01 E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2812%2970008-2

7 January 2021

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2812%2970008-2

7 January 2021

Spray drying TB vaccines for pulmonary administration

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2812%2970008-2

7 January 2021

Immunization by a bacterial aerosol

1 reference

https://api.crossref.org/works/10.1016%2FS1472-9792%2812%2970008-2

7 January 2021

10.1016/S1472-9792(12)70008-2

Identifiers

DOI

1 reference

16 March 2018

1 reference

16 March 2018